Long-Term Clinical Benefits of Pulsed Field Ablation in Paroxysmal Atrial Fibrillation: Subanalyses From the Multicenter inspIRE Trial
Status In-Process Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu dopisy
PubMed
40276859
PubMed Central
PMC12094256
DOI
10.1161/circep.124.013465
Knihovny.cz E-zdroje
- Klíčová slova
- atrial fibrillation, catheters, heart atria, pulmonary veins, tachycardia,
- Publikační typ
- dopisy MeSH
Cardiology Department Jessa Hospitals Hasselt Belgium
Cardiovascular Center OLV Hospital Aalst Belgium
Department for Cardiovascular Diseases University Hospital Center Split Croatia
Department für Kardiologie und Elektrophysiologie Ordensklinikum Linz GmbH Elisabethinen Austria
Department of Cardiology AZ Sint Jan Brugge Belgium
Department of Cardiology Na Homolce Hospital Prague Czech Republic
Department of Cardiology Ziekenhuis Oost Limburg Campus Genk Belgium
Department of Electrophysiology and Cardiac Stimulation Centre Hospitalier Universitaire de Bordeaux
Dipartimento di Cardiologia Ospedale Generale Regionale F Miulli UOC Cardiologia Bari Italy
Division of Cardiology McGill University Health Centre Montreal Quebec Canada
Division of Cardiology Medical University Graz Austria
Electrophysiology Laboratory London Health Sciences Centre London Ontario Canada
Helmsley Electrophysiology Center Mount Sinai Fuster Heart Hospital New York NY
Zobrazit více v PubMed
Verma A, Haines DE, Boersma LV, Sood N, Natale A, Marchlinski FE, Calkins H, Sanders P, Packer DL, Kuck KH, et al. ; PULSED AF Investigators. Influence of monitoring and atrial arrhythmia burden on quality of life and health care utilization in patients undergoing pulsed field ablation: a secondary analysis of the PULSED AF trial. Heart Rhythm. 2023;20:1238–1245. doi: 10.1016/j.hrthm.2023.05.018 PubMed
De Potter T, Grimaldi M, Duytschaever M, Anic A, Vijgen J, Neuzil P, Van Herendael H, Verma A, Skanes A, Scherr D, et al. ; inspIRE Trial Investigators. Predictors of success for pulmonary vein isolation with pulsed field ablation using a variable loop catheter with 3D mapping integration: complete 12-month outcomes from inspIRE. Circ Arrhythm Electrophysiol. 2024;17:e012667. doi: 10.1161/CIRCEP.123.012667 PubMed PMC
Duytschaever M, De Potter T, Grimaldi M, Anic A, Vijgen J, Neuzil P, Van Herendael H, Verma A, Skanes A, Scherr D, et al. ; inspIRE Trial Investigators. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study. Circ Arrhythm Electrophysiol. 2023;16:e011780. doi: 10.1161/CIRCEP.122.011780 PubMed PMC
Spertus J, Dorian P, Bubien R, Lewis S, Godejohn D, Reynolds MR, Lakkireddy DR, Wimmer AP, Bhandari A, Burk C. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4:15–25. doi: 10.1161/CIRCEP.110.958033 PubMed
Holmes DN, Piccini JP, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, O’Brien EC, Reiffel JA, Naccarelli GV, Ezekowitz MD, et al. . Defining clinically important difference in the atrial fibrillation effect on quality-of-life score. Circ Cardiovasc Qual Outcomes. 2019;12:e005358. doi: 10.1161/CIRCOUTCOMES.118.005358 PubMed